{
    "organizations": [],
    "uuid": "4351a771d53c659bc5bc67f05700d63c7c38422e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-redwood-pharma-acquires-intellectu/brief-redwood-pharma-acquires-intellectual-property-rights-idUSASM000K8H",
    "ord_in_thread": 0,
    "title": "BRIEF-Redwood Pharma Acquires Intellectual Property Rights",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 8 (Reuters) - Redwood Pharma Ab:\n* REDWOOD PHARMA ACQUIRES INTELLECTUAL PROPERTY RIGHTS * HAS ENTERED INTO AN AGREEMENT REGARDING ACQUISITION OF CERTAIN PATENT AND PATENT APPLICATIONS\n* PAYMENT WILL OCCUR THROUGH ISSUANCE OF 525,000 SHARES BY REDWOOD PHARMA.\n* REDWOOD ACQUIRES PATENT AND PATENT APPLICATIONS, AS WELL AS DATA, FOR A CONSIDERATION OF SEK 5.1 MILLION Source text for Eikon: Further company coverage: (Gdynia Newsroom)\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-03-08T23:57:00.000+02:00",
    "crawled": "2018-03-09T14:52:10.016+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "redwood",
        "pharma",
        "ab",
        "redwood",
        "pharma",
        "acquires",
        "intellectual",
        "property",
        "right",
        "entered",
        "agreement",
        "regarding",
        "acquisition",
        "certain",
        "patent",
        "patent",
        "application",
        "payment",
        "occur",
        "issuance",
        "share",
        "redwood",
        "pharma",
        "redwood",
        "acquires",
        "patent",
        "patent",
        "application",
        "well",
        "data",
        "consideration",
        "sek",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}